Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide

MLA

Instituto de Salud Carlos III, et al. Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1442723537&authtype=sso&custid=ns315887.

APA

Instituto de Salud Carlos III, European Commission, Centros de Investigación Biomédica en Red (España), Ministerio de Ciencia e Innovación (España), Junta de Andalucía, Santos, M., Corma-Gómez, A., Martín-Carmona, J., Pérez-García, M., Martín-Sierra, C., Rincón, P., González-Serna, A., Pineda, J. A., Real, L. M., & Macías, J. (2023). Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide.

Chicago

Instituto de Salud Carlos III, European Commission, Centros de Investigación Biomédica en Red (España), Ministerio de Ciencia e Innovación (España), Junta de Andalucía, Marta Santos, Anaïs Corma-Gómez, et al. 2023. “Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1442723537&authtype=sso&custid=ns315887.